$32.170
-1.165 (-3.62%)Al cierre
Noticias de KN
Eventos de KN
Company Reports Q3 Revenue of $184.0M, Beating Expectations
Reports Q3 revenue $184.0M, consensus $172.1M. "Total Company revenue grew 20% year over year in the third quarter, and our book-to-bill ratio in Precision Devices remained above one for the eighth consecutive quarter, reflecting continued order strength," CEO Jeffrey Niew said. "By executing our strategy-leveraging our differentiated technologies, developing custom products through close customer collaboration, and scaling production with our world-class operational capabilities-we delivered strong growth across the four major markets we serve: Medtech, Defense, Industrial, and Electrification. Additionally, at the mid-point of our fourth quarter guided range, full year 2026 revenue is expected to grow 16%. I am pleased with the Company's performance and excited about the opportunities ahead."
Knowles Projects FY26 Revenue at $689M
Knowles sees FY26 revenue $689M, consensus $666.6M
Sees Q4 Revenue of $180M-$190M
Sees Q4 revenue $180M-$190M, consensus $174.6M
Knowles Partners with Elucent Medical to Produce Smart Surgical Guidance Device
Knowles announced an agreement to produce Elucent Medical's smart surgical guidance device for use with its EnVisio In-Body Spatial IntelligenceTM System. Leveraging Knowles' micro molding capabilities and using a design-for-manufacturability, or DFM, optimization approach, Knowles worked with Elucent to iterate designs, identify tolerance and material improvement opportunities, and provide guidance throughout product design, development, and launch of their surgical guidance device.
Knowles Reports Q2 Revenue of $167M
Reports Q2 revenue $167M, consensus $156.97M. "We delivered second quarter revenues exceeding the high end of our guided range. Non-GAAP diluted EPS was above the high end of our guided range and cash from operations was within the guided range," commented Jeffrey Niew, President and CEO of Knowles.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.